Since our inception, we have been committed to our patients and their families. Our medicines treat life-threatening conditions that are extremely difficult to manage, with a tremendous impact on quality of life for patients and their loved ones. At United Therapeutics, we not only provide treatments, but we strive to ensure that patients have the support, education, and assistance they need when using our therapies to manage their disease.
15K+
patients on our therapies and benefiting from our solutions including our ex vivo lung perfusion (EVLP) service
34K+
patients supported on their treatment journey since 2010
$0
Co-pay cards for PH products available to eligible patients
*Data as of December 31, 2024
For additional information about how we address unserved patient needs and make sure no patient gets left behind, see:
| Patient Centricity Topic Overview | Link |
| Patient Support Programs | Link |
| PAH Initiative | Link |
| Product Pipeline | Link |
| Lung Bioengineering | Link |
| Clinical Trials | Link |
| Global Product Safety and Vigilance | Link |
Video Links:
